As part of a feasibility study, Royal Adelaide Hospital in South Australia has performed the first procedure using St. Jude Medical’s renal denervation catheter and generator system to treat resistant hypertension.

The design of the new catheter minimises the need for extensive catheter manipulation, which could potentially shorten procedure times, limit contrast use and reduce fluoroscopic exposure.

St. Jude Medical Cardiovascular Division president Frank Callaghan said the new technology could potentially benefit patients through an overall reduction in risks for cardiovascular side effects of hypertension, including death.

"We have leveraged our company’s extensive experience in ablation technologies to develop a renal denervation system that provides physicians with an alternative therapeutic option for patients with resistant hypertension,” Callaghan said.

The company expects a limited market launch in Europe before the end of 2012.


How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.